Literature DB >> 9418188

Contribution of antibody to neutrophil-mediated killing of Enterococcus faecalis.

M J Gaglani1, C J Baker, M S Edwards.   

Abstract

Late-onset septicemia due to Enterococcus faecalis is common among very low-birth weight neonates. These infants have low concentrations of placentally derived IgG and developmentally low levels of complement. The aim of the present study was to determine the contribution of antibody to in vitro neutrophil-mediated phagocytosis of E. faecalis. Antibody alone, as contained in an adult serum pool heated to inactivate complement, promoted only a modest reduction in the initial bacterial inoculum (50 +/- 12%) for 6 of 10 E. faecalis bacterial strains tested and allowed growth of the other four strains. In the presence of complement, NHS promoted > or = 90% reduction in the initial bacterial inoculum of two representative strains at serum concentrations as low as 0.5%. Hypogammaglobulinemic serum supported similar activity only at concentrations above 5%. Purification of IgG and IgM fractions from NHS revealed that IgM had the higher specific activity to promote phagocytic activity. Absorption to remove specific antibody significantly reduced bactericidal activity by normal human serum, complement-deficient sera, and hypogammaglobulinemic serum. Reconstitution of hypogammaglobulinemic serum with antibody as contained in 1% heated normal human serum or in immune globulin for intravenous use (1200 mg/dl) restored phagocytic activity. Thus, E. faecalis-specific antibody enhances PMN-mediated killing of this organism. Adjunctive therapy with intravenous immunoglobulin could augment the host response to enterococcal infections in infancy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9418188     DOI: 10.1023/a:1027371727225

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

Review 1.  Emergence of Enterococcus as a significant pathogen.

Authors:  R C Moellering
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

2.  Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.

Authors:  M S Edwards; C J Baker; D L Kasper
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

3.  Leukocyte function in normal and infected neonates.

Authors:  D C Anderson; L K Pickering; R D Feigin
Journal:  J Pediatr       Date:  1974-09       Impact factor: 4.406

4.  Deficiency of neutrophil bactericidal activity in term and preterm infants. A longitudinal study.

Authors:  G Chirico; M Marconi; M De Amici; A Gasparoni; G Mingrat; A Chiara; G Rondini; A G Ugazio
Journal:  Biol Neonate       Date:  1985

5.  Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci.

Authors:  M S Edwards; M R Wessels; C J Baker
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

6.  Deficient classical complement pathway activity in newborn sera.

Authors:  M S Edwards; G J Buffone; P A Fuselier; J L Weeks; C J Baker
Journal:  Pediatr Res       Date:  1983-08       Impact factor: 3.756

7.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

8.  Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-08-06       Impact factor: 17.586

9.  Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.

Authors:  D C Anderson; B J Hughes; C W Smith
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

10.  Neonatal enterococcal sepsis: case-control study and description of an outbreak.

Authors:  L M Luginbuhl; H A Rotbart; R R Facklam; M H Roe; J A Elliot
Journal:  Pediatr Infect Dis J       Date:  1987-11       Impact factor: 2.129

View more
  8 in total

1.  Detection of opsonic antibodies against Enterococcus faecalis cell wall carbohydrates in immune globulin preparations.

Authors:  M Hufnagel; K Sixel; F Hammer; A Kropec; I G Sava; C Theilacker; R Berner; J Huebner
Journal:  Infection       Date:  2014-05-23       Impact factor: 3.553

Review 2.  Pathogenicity of Enterococci.

Authors:  Elizabeth Fiore; Daria Van Tyne; Michael S Gilmore
Journal:  Microbiol Spectr       Date:  2019-07

3.  Naturally acquired antibodies against four Enterococcus faecalis capsular polysaccharides in healthy human sera.

Authors:  Markus Hufnagel; Andrea Kropec; Christian Theilacker; Johannes Huebner
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

4.  Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci.

Authors:  J Huebner; A Quaas; W A Krueger; D A Goldmann; G B Pier
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  Evidence that the enterococcal polysaccharide antigen gene (epa) cluster is widespread in Enterococcus faecalis and influences resistance to phagocytic killing of E. faecalis.

Authors:  Fang Teng; Karen D Jacques-Palaz; George M Weinstock; Barbara E Murray
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

6.  Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium.

Authors:  J Huebner; Y Wang; W A Krueger; L C Madoff; G Martirosian; S Boisot; D A Goldmann; D L Kasper; A O Tzianabos; G B Pier
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

7.  Inhibition of the Classical Pathway of Complement Activation Impairs Bacterial Clearance during Enterococcus faecalis Infection.

Authors:  Youssif M Ali; Ramadan Hassan; Eman M Rabie Shehab El-Din; Abdelaziz Elgaml
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

8.  Identification of the Streptococcus pyogenes surface antigens recognised by pooled human immunoglobulin.

Authors:  Mark Reglinski; Magdalena Gierula; Nicola N Lynskey; Robert J Edwards; Shiranee Sriskandan
Journal:  Sci Rep       Date:  2015-10-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.